The latest new contracts, like Locus Cell’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Locus Cell Partners with Cambium Bio for Phase III CDMO Manufacturing of Elate Ocular®.
Sep 29, 2025•9 months ago
Contract Type
partnership
TaiwanManufacturingBiotechnology
Description
Locus Cell has signed a Memorandum of Understanding with Cambium Bio for the contract development and manufacturing of Elate Ocular® related therapies. This partnership marks Locus Cell's first Phase III international CDMO project, enhancing their role in global pharmaceutical manufacturing.
Company Information
Company
Locus Cell
Location
Taiwan
About
Locus Cell is a leading regenerative medicine contract development and manufacturing organization (CDMO) based in Taiwan. The company specializes in providing innovative solutions for pharmaceutical and biotechnology partners. It boasts state-of-the-art facilities that comply with international regulatory standards, including FDA requirements.
TaiwanManufacturingBiotechnology